Form 4: Director Daniel Cancelmi Receives Acadia Healthcare Equity

Acadia Healthcare Company, Inc. director Daniel J. Cancelmi was granted 6,331 shares of common stock as part of a compensation arrangement.

Summary

• Director Daniel J. Cancelmi acquired 6,331 shares of Acadia Healthcare Company, Inc. (ACHC) common stock.
• The transaction occurred on May 6, 2026, at a price of $0.0 per share, representing an equity grant.
• Following this transaction, the reporting person holds a total of 12,956 shares directly.
• The granted shares are subject to a 3-year vesting schedule with equal annual installments starting May 6, 2027.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of immediate market impact.

Positives

• Alignment of director interests with shareholders through increased equity ownership.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

The shares are subject to a standard 3-year vesting schedule, indicating long-term retention incentives for the director.

Industry Context

StockSavvy.ai notes that equity grants to board members are standard corporate governance practices designed to align director incentives with long-term shareholder value creation in the healthcare services sector.

Comparison to Industry Standards

• The grant of equity to directors is a common practice among S&P 400 and healthcare sector companies to ensure board alignment.
• The 3-year vesting schedule is consistent with standard market practices for director compensation.

Corporate Governance

Stakeholder Impact

• Shareholders: Positive alignment of director interests with company performance.

Next Steps

• Vesting of the first installment of shares on May 6, 2027.

Key Dates

Keywords

Acadia Healthcare, ACHC, Form 4, Insider Transaction, Equity Grant, Director Compensation